Thromboxane b2

Thromboxane b2 is a lipid of Fatty Acyls (FA) class. Thromboxane b2 is associated with abnormalities such as endothelial dysfunction, Diabetes Mellitus, Non-Insulin-Dependent, Diabetes Mellitus, Ischemia and Thrombocytosis. The involved functions are known as Platelet Activation, Excretory function, Anabolism, Inflammation and mRNA Expression. Thromboxane b2 often locates in Endothelium, Hepatic and Microsomes, Liver. The associated genes with Thromboxane b2 are PTGS2 gene, prothrombin fragment 2 and CCL14 wt Allele.

Cross Reference

Introduction

To understand associated biological information of Thromboxane b2, we collected biological information of abnormalities, associated pathways, cellular/molecular locations, biological functions, related genes/proteins, lipids and common seen animal/experimental models with organized paragraphs from literatures.

What diseases are associated with Thromboxane b2?

Thromboxane b2 is suspected in endothelial dysfunction, Diabetes Mellitus, Non-Insulin-Dependent, Diabetes Mellitus, Ischemia, Thrombocytosis, Acute Coronary Syndrome and other diseases in descending order of the highest number of associated sentences.

Related references are mostly published in these journals:

Disease Cross reference Weighted score Related literature
Loading... please refresh the page if content is not showing up.

Possible diseases from mapped MeSH terms on references

We collected disease MeSH terms mapped to the references associated with Thromboxane b2

MeSH term MeSH ID Detail
Angina Pectoris D000787 27 associated lipids
Angina Pectoris, Variant D000788 3 associated lipids
Angina, Unstable D000789 14 associated lipids
Hypoxia D000860 23 associated lipids
Aortic Aneurysm D001014 8 associated lipids
Aortic Arch Syndromes D001015 2 associated lipids
Aortic Rupture D001019 3 associated lipids
Arrhythmias, Cardiac D001145 42 associated lipids
Arterial Occlusive Diseases D001157 12 associated lipids
Arteriosclerosis D001161 86 associated lipids
Per page 10 20 50 100 | Total 293

PubChem Associated disorders and diseases

What pathways are associated with Thromboxane b2

There are no associated biomedical information in the current reference collection.

PubChem Biomolecular Interactions and Pathways

Link to PubChem Biomolecular Interactions and Pathways

What cellular locations are associated with Thromboxane b2?

Related references are published most in these journals:

Location Cross reference Weighted score Related literatures
Loading... please refresh the page if content is not showing up.

What functions are associated with Thromboxane b2?


Related references are published most in these journals:

Function Cross reference Weighted score Related literatures

What lipids are associated with Thromboxane b2?

There are no associated biomedical information in the current reference collection.

What genes are associated with Thromboxane b2?

Related references are published most in these journals:


Gene Cross reference Weighted score Related literatures

What common seen animal models are associated with Thromboxane b2?

There are no associated biomedical information in the current reference collection.

NCBI Entrez Crosslinks

All references with Thromboxane b2

Download all related citations
Per page 10 20 50 100 | Total 6367
Authors Title Published Journal PubMed Link
Mizugaki M et al. Microdetermination of 11-dehydrothromboxane B3 in human urine by gas chromatography--selected-ion monitoring using (18O2) analogue as an internal standard. 1995 Rapid Commun. Mass Spectrom. pmid:8829485
Restori G et al. Effects of heparan-sulphate administration on clotting parameters and serum thromboxane B2 levels in cholesterol fed rabbits. 1992 Recenti Prog Med pmid:1561475
Strano A et al. [Formation of platelet thromboxane in a patient with type I glycogenosis]. 1985 Recenti Prog Med pmid:3868788
Nenci GG and Paliani U [Diabetes, coagulation and vascular events]. 2000 Recenti Prog Med pmid:10748654
Shimada N et al. Increased endothelin: nitric oxide ratio is associated with erythropoietin-induced hypertension in hemodialysis patients. 2003 Ren Fail pmid:12911161
Grekas D et al. Acute cyclosporin A renal dysfunction in dogs reversed by calcium antagonists and antiplatelet agents. 1992 Ren Fail pmid:1462000
Baylis C Effects of administered thromboxanes on the intact, normal rat kidney. 1987 Ren Physiol pmid:3447248
Eisenmann CJ and Miller RK Cadmium and glutathione: effect on human placental thromboxane and prostacyclin production. 1995 Jan-Feb Reprod. Toxicol. pmid:8520130
Ulbrich SE et al. Quantitative characterization of prostaglandins in the uterus of early pregnant cattle. 2009 Reproduction pmid:19470711
Neiman J Effects of ethanol on platelet thromboxane formation after ethanol withdrawal in chronic alcoholics: an in vitro study. 1988 Res Exp Med (Berl) pmid:3420300
Kiviniemi H and Rämo OJ The behaviour of prostanoids during the course of acute experimental pancreatitis in rats. 1986 Res Exp Med (Berl) pmid:3823620
Altavilla D et al. Effect of bacterial endotoxin on lipoxygenase and cyclo-oxygenase metabolites by rat neutrophils and correlation with cellular functional parameters. 1988 Res Exp Med (Berl) pmid:2832910
Raz A and Aharony D Prostaglandin biosynthesis in platelets: demonstration and role of prostaglandin H2 leads to E2 isomerase. 1978 Res. Commun. Chem. Pathol. Pharmacol. pmid:705027
Horiuchi H et al. 1,25-Dihydroxyvitamin D3 inhibits thromboxane release from activated macrophages. 1992 Res. Commun. Chem. Pathol. Pharmacol. pmid:1475528
Nakae H et al. Relationship between thromboxane B2 and 6-keto-prostaglandin F1 alpha in sepsis. 1994 Res. Commun. Chem. Pathol. Pharmacol. pmid:8008979
Pattison A et al. Nicotinic acid enhances the production of 6-ketoprostaglandin F1 alpha in human whole blood in vitro. 1987 Res. Commun. Chem. Pathol. Pharmacol. pmid:3575878
King JN et al. In vitro and ex vivo inhibition of canine cyclooxygenase isoforms by robenacoxib: a comparative study. 2010 Res. Vet. Sci. pmid:20004922
Sidhu P et al. Tissue chamber model of acute inflammation in farm animal species. 2003 Res. Vet. Sci. pmid:12507568
Taylor PM et al. Pharmacodynamics and enantioselective pharmacokinetics of carprofen in the cat. 1996 Res. Vet. Sci. pmid:8685536
Cambridge H et al. Radioimmunoassay of thromboxane B2 in horse plasma. 1987 Res. Vet. Sci. pmid:3589161
Bailey SR et al. Actions and interactions of ADP, 5- HT, histamine and PAF on equine platelets. 2000 Res. Vet. Sci. pmid:10756136
Semrad SD and Moore JN Effects of a specific thromboxane synthetase inhibitor in equine endotoxaemia. 1987 Res. Vet. Sci. pmid:3317581
Brentnall C et al. Potency and selectivity of carprofen enantiomers for inhibition of bovine cyclooxygenase in whole blood assays. 2012 Res. Vet. Sci. pmid:22703724
Hardee MM et al. Effects of flunixin meglumine, phenylbutazone and a selective thromboxane synthetase inhibitor (UK-38,485) on thromboxane and prostacyclin production in healthy horses. 1986 Res. Vet. Sci. pmid:3517992
Galbraith EA and McKellar QA Protein binding and in vitro serum thromboxane B2 inhibition by flunixin meglumine and meclofenamic acid in dog, goat and horse blood. 1996 Res. Vet. Sci. pmid:8819199
Landoni MF et al. Pharmacokinetics and pharmacodynamics of tolfenamic acid in calves. 1996 Res. Vet. Sci. pmid:8819190
Orr JA et al. Transient ventilatory responses to endotoxin infusion in the cat are mediated by thromboxane A2. 1993 Respir Physiol pmid:8210758
Shams H et al. Acid infusion elicits thromboxane A2-mediated effects on respiration and pulmonary hemodynamics in the cat. 1988 Respir Physiol pmid:3340817
Shams H et al. Cyclooxygenase inhibition and effects of hypoxia on pulmonary circulation and gas exchange in anesthetized dogs. 1989 Respir Physiol pmid:2497503
Nakano T et al. Effects of platelet depletion on PMA-induced acute lung injury in awake sheep. 1995 Respir Physiol pmid:8570923
Fujimoto K et al. Neutrophil elastase inhibitor reduces asthmatic responses in allergic sheep. 1995 Respir Physiol pmid:7541545
Nakano T et al. Role of pulmonary intravascular macrophages in anti-platelet serum-induced pulmonary hypertension in sheep. 1994 Respir Physiol pmid:7817044
Truog WE et al. Acute changes in vasoactive lipid mediators in experimental hyaline membrane disease. 1992 Respir Physiol pmid:1480845
LÃ¥stbom L et al. Mechanisms of 3-carene-induced bronchoconstriction in the isolated guinea pig lung. 1995 Respiration pmid:7569332
Ogletree ML et al. Direct and indirect effects of leukotriene D4 on the lungs of unanesthetized sheep. 1987 Respiration pmid:3116626
Mazzarella G et al. Protective effects of nedocromil sodium on cellular and biohumoral components present in the bronchial alveolar lavage fluid and in peripheral blood in atopic asthmatics. 1994 Respiration pmid:7973106
Burghuber OC et al. Inhibition of acetylcholine-induced bronchoconstriction in asthmatics by nifedipine. 1986 Respiration pmid:3823637
Zimmermann I et al. [Influence of vagus nerve, histamine, prostaglandin and catecholamine on airway obstruction]. 1984 Respiration pmid:6473921
Kubo K et al. A 21-aminosteroid, U-74006F, attenuates endotoxin-induced lung injury in awake sheep. 1999 Respirology pmid:10382236
Griffin MP et al. Ibuprofen therapy in experimental porcine gram-negative septic shock. 1991 Resuscitation pmid:1658896
Poubelle P et al. [Mononucleated phagocytes from rheumatoid synovial fluid. Synthesis of prostanoids and first pharmacological applications]. 1982 Rev Rhum Mal Osteoartic pmid:7123126
Herrera Hernández MF et al. [Immunoreactive urinary thromboxane B2 in experimental mesenteric thrombosis in dogs]. 1989 Apr-Jun Rev. Invest. Clin. pmid:2781174
Knijff-Dutmer EA et al. Platelet function is inhibited by non-selective non-steroidal anti-inflammatory drugs but not by cyclo-oxygenase-2-selective inhibitors in patients with rheumatoid arthritis. 2002 Rheumatology (Oxford) pmid:11961179
Baenkler HW et al. Eicosanoids from biopsy of normal and polypous nasal mucosa. 1996 Rhinology pmid:8938887
Altomonte L et al. Thromboxane production in diabetes mellitus. 1986 Oct-Dec Ric Clin Lab pmid:3576051
Shinohara M et al. [Responses to surgical stress in blood coagulation and fibrinolysis, platelet counts and thromboxane B2 after esophageal cancer operation]. 1997 Rinsho Byori pmid:9121003
Tada M et al. [Biochemistry of coronary artery disease--prostaglandins]. 1983 Rinsho Byori pmid:6361336
Kurata M [Relation between mouse peritoneal macrophage functions and prostaglandins]. 1983 Rinsho Byori pmid:6689184
Takeda H et al. [Alternations in coagulation and fibrinolysis associated with extracorporeal circulation--the role of vasoactive prostanoids]. 1984 Rinsho Kyobu Geka pmid:6395300
Bornman MS et al. Elevated thromboxane B2 levels during erection. 1985 S. Afr. Med. J. pmid:3839322
Guimarães PC et al. Variations in white blood count, thromboxane B2 levels and hematocrit in chronic venous hypertension. 1998 May-Jun Sao Paulo Med J pmid:9876450
Malý J et al. Migraine--a haematological disorder? 1995 Sb Ved Pr Lek Fak Karlovy Univerzity Hradci Kralove pmid:8685625
Luzzatto G et al. PF 4 versus beta TG as evidence for platelet activation in myeloproliferative disorders. 1985 Scand J Haematol pmid:2414843
Huijgens PC et al. Aspirin does not inhibit human megakaryocyte thromboxane synthesis in vivo. 1986 Scand J Haematol pmid:3081996
Bellucci S et al. Thrombocytopenia with thrombocytopathy possibly related to abnormalities of intracellular Ca++ fluxes and followed by the development of leukaemia. 1986 Scand J Haematol pmid:3085207
Kutti J et al. The effect of acetylsalicylic acid in 3 different formulations on in vitro and in vivo platelet function tests. An experimental study on healthy male volunteers. 1984 Scand J Haematol pmid:6719042
Jonsson CE et al. Prostaglandins and thromboxanes in burn injury in man. 1979 Scand J Plast Reconstr Surg pmid:451477
Wojakowski W and Gmiński J Plasma levels of von willebrand factor, endothelin-1, prostacyclin and thromboxane in children from families with high risk of premature coronary artery disease. 2001 Scand. J. Clin. Lab. Invest. pmid:11465346
Meen O et al. No case of COX-1-related aspirin resistance found in 289 patients with symptoms of stable CHD remitted for coronary angiography. 2008 Scand. J. Clin. Lab. Invest. pmid:17934975
Aursnes I et al. Low and high risk coronary patients discriminated by blood platelet fatty acid composition. 1986 Scand. J. Clin. Lab. Invest. pmid:3715364
Vicari AM and Macagni A Primary platelet activation in recent-onset type 1 diabetes mellitus. 1990 Scand. J. Clin. Lab. Invest. pmid:2144055
Khan I et al. Cyclooxygenase-2 inhibition and experimental colitis: beneficial effects of phosphorothioated antisense oligonucleotide and meloxicam. 2002 Scand. J. Gastroenterol. pmid:12523593
Wilder-Smith CH et al. Dose-effect comparisons of the CINOD AZD3582 and naproxen on upper gastrointestinal tract mucosal injury in healthy subjects. 2006 Scand. J. Gastroenterol. pmid:16497612
Arai M et al. Platelet dysfunction and alteration of prostaglandin metabolism after chronic alcohol consumption. 1986 Scand. J. Gastroenterol. pmid:3810010
van Ooijen B et al. Raised plasma thromboxane B2 levels in experimental acute necrotizing pancreatitis in rats. The effects of flunarizine, dazoxiben, and indomethacin. 1988 Scand. J. Gastroenterol. pmid:3363291
Sharon P et al. Prostanoid synthesis by cultured gastric and duodenal mucosa: Possible role in the pathogenesis of duodenal ulcer. 1983 Scand. J. Gastroenterol. pmid:6584967
Branski D et al. Effect of cimetidine on human gastric and duodenal prostanoid synthesis. 1984 Scand. J. Gastroenterol. pmid:6589742
Rainsford KD et al. Comparative effects of some non-steroidal anti-inflammatory drugs on the ultrastructural integrity and prostaglandin levels in the rat gastric mucosa: relationship to drug uptake. 1984 Scand. J. Gastroenterol. Suppl. pmid:6443622
Chiricolo M et al. Immune dysfunction in primary biliary cirrhosis. II. Increased production of prostaglandin E. 1989 Scand. J. Immunol. pmid:2789430
Maddox Y et al. A routine source of human peritoneal macrophages. 1984 Scand. J. Immunol. pmid:6701470
Trang LE et al. Levels of prostaglandins F2 alpha and E2 and thromboxane B2 in joint fluid in rheumatoid arthritis. 1977 Scand. J. Rheumatol. pmid:929121
Spence JD The arthritic patient with hypertension: selection of an NSAID. 1986 Scand. J. Rheumatol. Suppl. pmid:3541167
Kalaitzis C et al. Role of eicosanoids of the contralateral kidney in maintenance of two-kidney, one-clip renovascular hypertension in rats. 2007 Scand. J. Urol. Nephrol. pmid:17853043
Kalaitzis C et al. Effects of renal denervation of the contralateral kidney on blood pressure and sodium and eicosanoid excretion in the chronic phase of two-kidney, one-clip renovascular hypertension in rats. 2005 Scand. J. Urol. Nephrol. pmid:15764265
Katsumata M et al. Diphenylhydantoin: an alternative ligand of a glucocorticoid receptor affecting prostaglandin generation in A/J mice. 1982 Science pmid:6897299
Kalgutkar AS et al. Aspirin-like molecules that covalently inactivate cyclooxygenase-2. 1998 Science pmid:9596581
Michelassi F et al. Leukotriene D4: a potent coronary artery vasoconstrictor associated with impaired ventricular contraction. 1982 Science pmid:6808665
Vignon E et al. Effects of tiaprofenic acid on interleukin 1, phospholipase A2 activity, prostaglandins, neutral protease, and collagenase activity in rheumatoid synovial fluid. 1989 Semin. Arthritis Rheum. pmid:2544031
Fenner H Differentiating among nonsteroidal antiinflammatory drugs by pharmacokinetic and pharmacodynamic profiles. 1997 Semin. Arthritis Rheum. pmid:9219317
Schick BP and Schick PK Megakaryocyte biochemistry. 1986 Semin. Hematol. pmid:2935939
Challis JR and Patrick JE The production of prostaglandins and thromboxanes in the feto-placental unit and their effects on the developing fetus. 1980 Semin. Perinatol. pmid:6992278
Cassin S Role of prostaglandins, thromboxanes, and leukotrienes in the control of the pulmonary circulation in the fetus and newborn. 1987 Semin. Perinatol. pmid:3551084
Ulutin ON Clinical effectiveness of defibrotide in vaso-occlusive disorders and its mode of actions. 1988 Semin. Thromb. Hemost. pmid:2848323
Messmore HL et al. Molecular markers of platelet activation. 1984 Semin. Thromb. Hemost. pmid:6240115
Haubelt H et al. Can platelet function tests predict the clinical efficacy of aspirin? 2005 Semin. Thromb. Hemost. pmid:16149017
Abbate R et al. Defibrotide reduces monocyte PAI-2 and procoagulant activity. 1995 Semin. Thromb. Hemost. pmid:7660147
Coppola A et al. Homocysteine, coagulation, platelet function, and thrombosis. 2000 Semin. Thromb. Hemost. pmid:11011842
Fareed J et al. Molecular markers of hemostatic activation in atherosclerosis: a new concept in diagnostic profiling of endogenous pathophysiologic transition. 1986 Semin. Thromb. Hemost. pmid:2943019
Fareed J et al. Molecular markers of contrast media-induced adverse reactions. 1984 Semin. Thromb. Hemost. pmid:6393351
Brace LD and Fareed J An objective assessment of the interaction of heparin and its fractions with human platelets. 1985 Semin. Thromb. Hemost. pmid:4035366
He B et al. [Effect of salt-loading on prostacyclin and thromboxane metabolism in kidney]. 1991 Sheng Li Xue Bao pmid:1754905
Zhao ZQ et al. [Effect of cardiac sympathetic nerves on changes of TXB2 and 6-keto-PGF1 alpha in venous blood of ischemic myocardium]. 1989 Sheng Li Xue Bao pmid:2762830
Hu DH [Effects of taurine enhancement of synthesis of TxA2 and PGI2 in cultured intra-pulmonary arteriolar smooth muscle cells under acute hypoxia]. 1998 Sheng Li Xue Bao pmid:11324559
Hu DH et al. [Effects of hypoxia and anisodamine on products of TXA2 and PGI2 in cultured intra-pulmonary arteriolar smooth muscle cells]. 1997 Sheng Li Xue Bao pmid:9863190
Yan GT et al. [Tumor necrosis factor induced enhancement of neutrophil chemotaxis and adhesion through mediating of phospholipase A2 activation]. 1995 Sheng Li Xue Bao pmid:8762444
Li HP et al. [The relationship between the activity of phospholipase A2 and acute hypoxic pulmonary arterial pressure]. 1997 Sheng Li Xue Bao pmid:9863193
Zhang M et al. [Reduction of incidence of ischemia-reperfusion induced ventricular fibrillation by captopril]. 1995 Sheng Li Xue Bao pmid:8762446
Kruse-Elliott KT et al. Attenuation of endotoxin-induced pathophysiology by a new potent PAF receptor antagonist. 1996 Shock pmid:8721386
Yokoyama Y et al. Up-regulated thromboxane production in the rat liver with biliary obstruction does not contribute to promote hepatic injury. 2008 Shock pmid:17885643
Wagner RS et al. Activation of thromboxane A2 receptors alters lipopolysaccharide-induced adherence of THP-1 cells. 1996 Shock pmid:8821102